113 related articles for article (PubMed ID: 35114955)
1. Initiating second-line antidiabetic medication among older adults with type 2 diabetes on Metformin.
DeCarlo K; Wallia A; Kang RH; Cooper A; Cherupally M; Harris SA; Aikman C; Liss DT; Ackermann RT; O'Brien MJ
BMC Geriatr; 2022 Feb; 22(1):97. PubMed ID: 35114955
[TBL] [Abstract][Full Text] [Related]
2. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.
McCoy RG; Van Houten HK; Deng Y; Mandic PK; Ross JS; Montori VM; Shah ND
JAMA Netw Open; 2021 Feb; 4(2):e2035792. PubMed ID: 33523188
[TBL] [Abstract][Full Text] [Related]
4. Predictors of emergency department and outpatient visits for hypoglycemia in type 2 diabetes: an analysis of a large US administrative claims database.
Simeone JC; Quilliam BJ
Ann Pharmacother; 2012 Feb; 46(2):157-68. PubMed ID: 22234990
[TBL] [Abstract][Full Text] [Related]
5. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
6. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic medication use during pregnancy: an international utilization study.
Cesta CE; Cohen JM; Pazzagli L; Bateman BT; Bröms G; Einarsdóttir K; Furu K; Havard A; Heino A; Hernandez-Diaz S; Huybrechts KF; Karlstad Ø; Kieler H; Li J; Leinonen MK; Gulseth HL; Tran D; Yu Y; Zoega H; Odsbu I
BMJ Open Diabetes Res Care; 2019; 7(1):e000759. PubMed ID: 31798900
[TBL] [Abstract][Full Text] [Related]
8. Capitalizing on prescribing pattern variation to compare medications for type 2 diabetes.
Prentice JC; Conlin PR; Gellad WF; Edelman D; Lee TA; Pizer SD
Value Health; 2014 Dec; 17(8):854-62. PubMed ID: 25498781
[TBL] [Abstract][Full Text] [Related]
9. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
10. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
[TBL] [Abstract][Full Text] [Related]
11. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
12. Glycemic Outcomes of Second-Line Diabetes Drug Choice in a Real-World Population.
Wallia A; O'Brien MJ; Liss DT; Kang RH; Cooper AJ; Gilmer A; Ackermann RT
Mayo Clin Proc Innov Qual Outcomes; 2021 Jun; 5(3):675-681. PubMed ID: 34195559
[TBL] [Abstract][Full Text] [Related]
13. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
Xu Y; Pilla SJ; Alexander GC; Murimi IB
PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
[TBL] [Abstract][Full Text] [Related]
14. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
[TBL] [Abstract][Full Text] [Related]
15. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus.
Bolen S; Feldman L; Vassy J; Wilson L; Yeh HC; Marinopoulos S; Wiley C; Selvin E; Wilson R; Bass EB; Brancati FL
Ann Intern Med; 2007 Sep; 147(6):386-99. PubMed ID: 17638715
[TBL] [Abstract][Full Text] [Related]
16. Exploration of Residual Confounding in Analyses of Associations of Metformin Use and Outcomes in Adults With Type 2 Diabetes.
Powell M; Clark C; Alyakin A; Vogelstein JT; Hart B
JAMA Netw Open; 2022 Nov; 5(11):e2241505. PubMed ID: 36367726
[TBL] [Abstract][Full Text] [Related]
17. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes.
Cohen FJ; Neslusan CA; Conklin JE; Song X
Diabetes Care; 2003 Jun; 26(6):1847-51. PubMed ID: 12766121
[TBL] [Abstract][Full Text] [Related]
18. Trends in insulin initiation and treatment intensification among patients with type 2 diabetes.
Patrick AR; Fischer MA; Choudhry NK; Shrank WH; Seeger JD; Liu J; Avorn J; Polinski JM
J Gen Intern Med; 2014 Feb; 29(2):320-7. PubMed ID: 24101534
[TBL] [Abstract][Full Text] [Related]
19. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.
Wheeler S; Moore K; Forsberg CW; Riley K; Floyd JS; Smith NL; Boyko EJ
Diabetologia; 2013 Sep; 56(9):1934-43. PubMed ID: 23797633
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
